At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …

(1) Background: Numerous vaccines are under preclinical and clinical development for
prevention of severe course and lethal outcome of coronavirus disease 2019 (COVID-19). In …

This paper aims to go deeper into how a firm executes digital transformation in marketing.
The experiences discussed in this article will give insight from a business practice …

With dermatologic side effects being fairly prevalent following vaccination against COVID‐
19, and the multitude of studies aiming to report and analyze these adverse events, the need …

The temporal association had been reported between vaccination and exacerbation of
psoriasis, and episodes of psoriasis flare-up have recently been attributed to COVID-19 …

1 Zuberbier T, Aberer W, Asero R et al. The EAACI/GA2LEN/EDF/WAO guideline for the
definition, classification, diagnosis and management of urticaria. Allergy 2018; 73: 1393 …

3 Yoshida A, Watanabe M, Okubo A, Kawashima H. Clinical characteristics of scleritis
patients with emphasized comparison of associated systemic diseases (anti-neutrophil …

Vaccination has been a game changer in our efforts to address the coronavirus disease
2019 (COVID-19) pandemic. However, the disease might still represent a clinical crisis for …

Patients with immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis
and inflammatory bowel disease, are at increased risk of infection. International guidelines …

Coronavirus disease 2019 (COVID-19) is a highly contagious viral disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has various effects on …